Effects of caffeine on the freezing of gait in Parkinson's disease

Movement Disorders

Volumn 22, Issue 5, 2007, Pages 710-712

  Kitagawa, Mayumi ^a   Houzen, Hideki ^b   Tashiro, Kunio ^c  

^a Sapporo Azabu Neurosurgical Hospital   (Japan)

^b Obihiro Kosei Hospital   (Japan)

^c HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Adenosine; Caffeine; Freezing of gait; Heel off; Parkinson's disease

Indexed keywords

CAFFEINE;

ADULT; AGED; AKINESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FREEZING OF GAIT; GAIT DISORDER; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR;

AGED; AGED, 80 AND OVER; CAFFEINE; DRUG TOLERANCE; FEMALE; FOLLOW-UP STUDIES; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; RECEPTOR, ADENOSINE A1; RECEPTORS, ADENOSINE A2;

EID: 34249064161     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21208     Document Type: Article

References (12)

1. Schaafsma JD, Balash Y, Gurevich T, Bartels AL, Hausdorff JM, Giladi N. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur J Neurol 2003;10:391-398.
2. Ouchi Y, Kanno T, Okada H, et al. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease. Brain 2001;124:784-792.
3. Le Moine C, Svenningsson P, Fredholm BB, Bloch B. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression. J Neurosci 1997;17:8038-8048.
4. Quarta D, Ferre S, Solinas M, et al. Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem 2004;88:1151-1158.
5. Bara-Jimenez W, Sherzai A, Dimitrova T, et al. Adenosine A(2A) receptor antagonist treatment of Parkinson's disease. Neurology 2003;61:293-296.
6. Svenningsson P, Nomikos GG, Fredholm BB. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J Neurosci 1999;19:4011-4022.
7. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
8. Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 2000;6:165-170.
9. Nieuwboer A, Dom R, De Weerdt W, Desloovere K, Janssens L, Stijn V. Electromyographic profiles of gait prior to onset of freezing episodes in patients with Parkinson's disease. Brain 2004;127:1650-1660.
10. Ueno E, Yanagisawa N, Takami M. Gait disorders in parkinsonism: a study with floor reaction forces and EMG. Adv Neurol 1993;60:414-418.
11. Aoyama S, Kase H, Borrelli E. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist. J Neurosci 2000;20:5848-5852.
12. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999;51:83-133.